Description:Ysios Capital is a prominent Spanish venture capital firm that specializes in providing private equity financing to early and mid-stage life science companies engaged in developing disruptive therapeutic products and innovative platform technologies. Established in 2008, Ysios Capital has successfully managed over USD 420 million across three dedicated funds focused on life sciences. The firm is guided by a team of seasoned professionals with extensive experience in building and nurturing biotech companies, positioning Ysios Capital as a key player in the investment landscape of the life sciences sector. With its strategic approach and commitment to fostering innovation, Ysios Capital continues to contribute significantly to the advancement of transformative healthcare solutions.